Recordati Rare Diseases North America
Peter H. Strauss is an accomplished executive with extensive experience in the pharmaceutical and healthcare industries. Currently serving as Vice President Endocrinology & Head of Market Access at Recordati Rare Diseases Inc., Peter has previously held key positions such as Vice President-Commercial Operations in the Metabolic Business Unit and Director of US Marketing for Orthopedics/Endocrinology at Ferring Pharmaceuticals. Peter's background includes significant roles at Merck as Global Marketing Director for Surgery and Anesthesia, as well as Antibiotics, and Director of Commercial Operations for Oncology. Prior positions include National Operations Manager at Schering-Plough and various managerial roles at Pfizer, including District Manager and Hospital Training Manager. Peter H. Strauss earned a Bachelor of Science degree in Biology from the University of North Carolina at Charlotte.
This person is not in any teams
Recordati Rare Diseases North America
1 followers
Recordati Rare Diseases Inc. (RRD) markets products to treat rare diseases. RRD is a member of the Recordati Group, which includes Recordati S.p.A., Orphan Europe, among other companies around the globe. The Recordati Group, which was established in 1926 currently employs more than 4,000 worldwide. The RRD mission is to reduce the impact of extremely rare and devastating diseases by providing urgently needed therapies. We work side-by-side with rare disease communities to increase awareness, improve diagnosis and expand availability of treatments for people with rare diseases.